H. van Slooten
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 4
-
- Pituitary Gland Disorders and Treatments 3
- Genetics top 5%
- Glioma Diagnosis and Treatment 3
- BRCA gene mutations in cancer 1
- Surgery top 10%
- Adrenal and Paraganglionic Tumors 4
-
- Patient-Provider Communication in Healthcare 2
-
- Lanthanide and Transition Metal Complexes 1
-
- Medical Imaging Techniques and Applications 1
H. van Slooten
10 papers receiving 668 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 379
- Endocrinology, Diabetes and Metabolism 278
- Genetics 163
- Surgery 493
- Neurology 91
Countries citing papers authored by H. van Slooten
This map shows the geographic impact of H. van Slooten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. van Slooten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. van Slooten more than expected).
Fields of papers citing papers by H. van Slooten
This network shows the impact of papers produced by H. van Slooten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. van Slooten. The network helps show where H. van Slooten may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H. van Slooten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 26 | |
| 2 | 2006 | 35 | |
| 3 | 2001 | 73 | |
| 4 | 1985 | 241 | |
| 5 | 1984 | 140 | |
| 6 | 1984 | 45 | |
| 7 | CAP (cyclophosphamide, doxorubicin, and cisplatin) regimen in adrenal cortical carcinoma. | 1983 | 37 |
| 8 | 1982 | 31 | |
| 9 | 1981 | 55 | |
| 10 | 1979 | 25 |
About H. van Slooten
H. van Slooten is a scholar working on Genetics, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 10 papers that have together received 708 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Adrenal and Paraganglionic Tumors (4 papers), Pituitary Gland Disorders and Treatments (3 papers), Glioma Diagnosis and Treatment (3 papers), Patient-Provider Communication in Healthcare (2 papers), Lanthanide and Transition Metal Complexes (1 paper), Medical Imaging Techniques and Applications (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Cancer Research (379 citations), Endocrinology, Diabetes and Metabolism (278 citations) and Genetics (163 citations). H. van Slooten has collaborated with scholars based in Netherlands. Frequent co-authors include A. J. Moolenaar, D. Smeenk, Arnoud P. van Seters, A.T. van Oosterom, S.J.T. Jansen, Anne M. Stiggelbout, Jan B. Vermorken, Herbert M. Pinedo, M. Nooij and J. Kievit. Their work appears in journals such as Cancer, British Journal of Cancer and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.